Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Tonix Pharmaceuticals Holding Corp TNXP

Healthcare Biotechnology
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include Tonmya (TNX-102 SL), TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801 and TNX-1800... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:TNXP)

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

GlobeNewswire 6 days ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

GlobeNewswire 6 days ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

Accesswire 10 days ago

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

GlobeNewswire 11 days ago

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

GlobeNewswire 11 days ago

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire 12 days ago

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

GlobeNewswire November 4, 2024

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

GlobeNewswire November 1, 2024

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

GlobeNewswire October 29, 2024
View More News ››

Opinion & Analysis (NDAQ:TNXP)

Eight ways to leverage the small-cap biotech bull market: Ajay Tandon and Jay Albany of SeeThruEquity

Gail Dutton October 30, 2015
View More Opinion ››

Bullboard Posts (NDAQ:TNXP)

TNXP targeting 0.15

This appears to be a typical pump and dump play with no real news driving the action. Massive volume at 130M suggests a short opportunity...
StockChaser217 - 4 days ago

InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NA

Breaking News: $TNXP InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at ThinkEquity ConferenceTonix...
whytestocks - October 25, 2024

Tonix Pharmaceuticals Receives First Contract Payment from U

JUST IN: $TNXP Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of...
whytestocks - October 17, 2024

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL

BREAKING NEWS: $TNXP Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S...
whytestocks - October 16, 2024

InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NA

Just In: $TNXP InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Featured in Post Discussing Nonaddictive...
whytestocks - October 1, 2024

BioMedNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASD

BREAKING NEWS: $TNXP BioMedNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports TNX-801 Aligns with WHO Preferred TPP...
whytestocks - September 16, 2024
View more Bullboard ››

Bank of Montreal

Bank of Montreal

Bank of Montreal (BMO) is a Canada-based company, which offers a wide range of personal banking services. The Company is ...
View More »